Synthomer plc
Winter trading statement
Synthomer plc ('Synthomer' or 'the Group') today
issues a scheduled update on trading for the twelve months to 31
December 2023.
We expect to report revenue of £2.0bn and
underlying EBITDA in the range of £140-144m for the continuing
Group in 2023. Year-end net debt is expected to be £499m, ahead of
our expectations as a result of strong cash delivery in the final
quarter. Since the start of 2023 we have reduced net debt by half,
through the rights issue, divestment programme and our strong focus
on cash conversion.
Trading in the fourth quarter was consistent
with trends throughout 2023, with subdued volumes and limited
visibility reflecting ongoing challenging macro conditions
throughout the chemicals industry. Our more differentiated
speciality businesses continue to be significantly more resilient
in terms of volumes and pricing compared to our base businesses,
which reinforces our determination to deliver the strategic
refocusing of the Group set out in October 2022. Coatings and
Construction Solutions (CCS), our most speciality-weighted
division, delivered a resilient final quarter, its fourth of the
year. Adhesive Solutions (AS) experienced increased pricing
pressure from global competitors in its base products towards the
end of the year although its speciality businesses remained more
robust, and we continue to work through the reliability and supply
chain challenges described previously. In Health & Protection
and Performance Materials (HPPM), our nitrile butadiene business
experienced a modest improvement in volumes in the fourth
quarter.
The Group has the operating capacity to deliver
significant progress in volume, revenue, EBITDA and cash generation
as end market demand recovers, although visibility as to the timing
of this remains limited at present. Therefore, for prudence, we are
progressing a dialogue with our lending banks to extend the period
of temporary covenant relaxation to ensure that we maintain
appropriate headroom while trading conditions remain
subdued.
In 2024, the Group will continue to focus on
delivering our speciality solutions strategy, including portfolio
management, alongside our ongoing activities to generate robust
cash flow and successfully navigate through current uncertainties
in our markets. In addition to further progress with our previously
announced actions to reduce cost, complexity and improve site
reliability, we have commenced a procurement optimisation programme
which is expected to deliver significant additional savings in 2024
and 2025. These actions will be partially offset by some increases
in operating overheads, mainly due to wage inflation and
normalisation of bonus accrual. We remain confident that
Synthomer's medium-term earnings power is more than double recent
levels, through a combination of our near-term actions, end market
volume recovery and strategic delivery.
Commenting,
Synthomer CEO Michael Willome said:
"We continue to execute our speciality solutions
strategy, repositioning the Group to deliver on its substantial
potential for value creation as market conditions begin to improve.
In the near term, our focus remains on enhancing our strong
positions in key speciality end-markets, optimising our business
portfolio and cost position, and sustaining our demonstrated
ability to generate free cash flow despite the challenging demand
environment."
Further information:
Investors: Faisal Tabbah, Vice
President Investor Relations
|
Tel: +44 (0) 1279 775 306
|
Media: Charles Armitstead,
Teneo
|
Tel: +44 (0) 7703 330 269
|
Notes
Legal Entity Identifier (LEI): 213800EHT3TI1KPQQJ56. Classification as per DTR 6 Annex 1R: 3.1.
Synthomer plc is a leading supplier
of high-performance speciality polymers and ingredients for
coatings, construction, adhesives, and healthcare end markets.
Headquartered in London, UK and listed there since 1971, we employ
around 4,400 employees across nearly 40 locations across Europe,
USA and Asia. With more than 6,000 customers and £2.4bn in
continuing revenue in 2022, our three divisions are aligned to our
end markets which play an important role in global megatrends
including urbanisation, climate change, and economic and
demographic shifts. In Coatings & Construction Solutions, our
tailored solutions enhance the sustainability and performance of a
range of products such as architectural and masonry coatings,
mortar modification, fibre bonding, waterproofing and flooring,
while our energy solutions promote drilling stability in the
challenging operating environments of the oil and gas industry.
Adhesive Solutions is a leading supplier of products that bond,
modify and compatibilise surfaces and components for a range of end
markets including tapes and labels, packaging, hygiene, tyres and
plastics. In Health & Protection and Performance Materials we
are a world-leading supplier of water-based polymers for medical
gloves and a major European manufacturer of high-performance
binders, foams and other products for a range of niche
applications. Our purpose is creating innovative and sustainable
solutions for the benefit of customers and society. Around 20% of
our sales volumes are from new and patent protected products. At
our innovation hubs in the UK, Germany, Malaysia and Ohio, USA we
collaborate closely with our customers to develop new products
tailored to their needs while also minimising environmental impact.
We are working to embed sustainability in everything we do; we have
reduced our scope 1 and 2 carbon footprint by one third since 2019,
and our 2030 decarbonisation targets have been approved by the
Science Based Targets initiative as being in line with what the
latest climate science says is necessary to meet the goals of the
Paris Agreement. Since 2021 we have held the London Stock Exchange
Green Economy Mark, which recognises green technology businesses
making a significant contribution to a more sustainable, low-carbon
economy. Find us at www.synthomer.com
or search for Synthomer on LinkedIn.